Cambridge Investment Research Advisors’s Medical Properties Trust MPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.78M | Sell |
601,230
-8,978
| -1% | -$44.5K | 0.01% | 1431 |
|
|
2026
Q1 | $2.83M | Buy |
610,208
+6,373
| +1% | +$33.2K | 0.01% | 1324 |
|
|
2025
Q4 | $3.02M | Buy |
603,835
+66,883
| +12% | +$348K | 0.01% | 1207 |
|
|
2025
Q3 | $2.72M | Buy |
536,952
+51,776
| +11% | +$228K | 0.01% | 1267 |
|
|
2025
Q2 | $2.09M | Buy |
485,176
+21,079
| +5% | +$104K | 0.01% | 1403 |
|
|
2025
Q1 | $2.8M | Sell |
464,097
-4,315
| -0.9% | -$21.8K | 0.01% | 1145 |
|
|
2024
Q4 | $1.85M | Buy |
468,412
+44,005
| +10% | +$197K | 0.01% | 1412 |
|
|
2024
Q3 | $2.48M | Buy |
424,407
+43,918
| +12% | +$217K | 0.01% | 1189 |
|
|
2024
Q2 | $1.64M | Buy |
380,489
+7,671
| +2% | +$36.8K | 0.01% | 1428 |
|
|
2024
Q1 | $1.75M | Buy |
372,818
+40,857
| +12% | +$156K | 0.01% | 1354 |
|
|
2023
Q4 | $1.63M | Sell |
331,961
-80,459
| -20% | -$394K | 0.01% | 1332 |
|
|
2023
Q3 | $2.25M | Sell |
412,420
-2,085
| -0.5% | -$16.7K | 0.01% | 1059 |
|
|
2023
Q2 | $3.84M | Buy |
414,505
+13,452
| +3% | +$114K | 0.02% | 794 |
|
|
2023
Q1 | $3.3M | Buy |
401,053
+99,534
| +33% | +$1.1M | 0.02% | 838 |
|
|
2022
Q4 | $3.36M | Buy |
301,519
+106,182
| +54% | +$1.23M | 0.02% | 796 |
|
|
2022
Q3 | $2.32M | Buy |
195,337
+16,207
| +9% | +$245K | 0.01% | 959 |
|
|
2022
Q2 | $2.73M | Buy |
179,130
+24,397
| +16% | +$439K | 0.01% | 888 |
|
|
2022
Q1 | $3.27M | Buy |
154,733
+5,057
| +3% | +$109K | 0.02% | 865 |
|
|
2021
Q4 | $3.54M | Buy |
149,676
+699
| +0.5% | +$15K | 0.02% | 825 |
|
|
2021
Q3 | $2.99M | Sell |
148,977
-4,696
| -3% | -$96.2K | 0.01% | 876 |
|
|
2021
Q2 | $3.09M | Sell |
153,673
-1,640
| -1% | -$35.1K | 0.01% | 876 |
|
|
2021
Q1 | $3.31M | Buy |
155,313
+12,016
| +8% | +$258K | 0.02% | 751 |
|
|
2020
Q4 | $3.12M | Buy |
143,297
+5,875
| +4% | +$114K | 0.02% | 696 |
|
|
2020
Q3 | $2.42M | Sell |
137,422
-79,843
| -37% | -$1.49M | 0.02% | 713 |
|
|
2020
Q2 | $4.08M | Buy |
217,265
+6,975
| +3% | +$124K | 0.03% | 507 |
|
|
2020
Q1 | $3.64M | Buy |
210,290
+9,747
| +5% | +$204K | 0.03% | 467 |
|
|
2019
Q4 | $4.23M | Buy |
200,543
+35,972
| +22% | +$728K | 0.03% | 526 |
|
|
2019
Q3 | $3.22M | Sell |
164,571
-11,007
| -6% | -$202K | 0.03% | 573 |
|
|
2019
Q2 | $3.06M | Buy |
175,578
+46,289
| +36% | +$833K | 0.03% | 561 |
|
|
2019
Q1 | $2.39M | Buy |
129,289
+17,343
| +15% | +$309K | 0.02% | 647 |
|
|
2018
Q4 | $1.8M | Buy |
111,946
+23,210
| +26% | +$367K | 0.02% | 673 |
|
|
2018
Q3 | $1.32M | Sell |
88,736
-4,194
| -5% | -$61.2K | 0.01% | 872 |
|
|
2018
Q2 | $1.3M | Buy |
92,930
+17,828
| +24% | +$236K | 0.01% | 840 |
|
|
2018
Q1 | $976K | Sell |
75,102
-1,973
| -3% | -$25.3K | 0.01% | 955 |
|
|
2017
Q4 | $1.06M | Sell |
77,075
-2,138
| -3% | -$28.9K | 0.01% | 870 |
|
|
2017
Q3 | $1.04M | Buy |
79,213
+14,148
| +22% | +$182K | 0.01% | 834 |
|
|
2017
Q2 | $837K | Sell |
65,065
-1,504
| -2% | -$20K | 0.01% | 898 |
|
|
2017
Q1 | $858K | Buy |
66,569
+10,496
| +19% | +$134K | 0.01% | 801 |
|
|
2016
Q4 | $690K | Buy |
56,073
+11,497
| +26% | +$149K | 0.01% | 854 |
|
|
2016
Q3 | $658K | Sell |
44,576
-2,543
| -5% | -$38.5K | 0.01% | 893 |
|
|
2016
Q2 | $717K | Sell |
47,119
-5,333
| -10% | -$75.5K | 0.02% | 766 |
|
|
2016
Q1 | $681K | Buy |
52,452
+17,272
| +49% | +$197K | 0.02% | 736 |
|
|
2015
Q4 | $405K | Buy |
35,180
+7,826
| +29% | +$89.4K | 0.01% | 967 |
|
|
2015
Q3 | $303K | Buy |
27,354
+163
| +0.6% | +$2.02K | 0.01% | 1019 |
|
|
2015
Q2 | $356K | Sell |
27,191
-913
| -3% | -$12.7K | 0.01% | 976 |
|
|
2015
Q1 | $414K | Sell |
28,104
-850
| -3% | -$12.6K | 0.01% | 889 |
|
|
2014
Q4 | $399K | Buy |
28,954
+847
| +3% | +$11.3K | 0.01% | 882 |
|
|
2014
Q3 | $345K | Sell |
28,107
-38,950
| -58% | -$518K | 0.01% | 1018 |
|
|
2014
Q2 | $888K | Buy |
67,057
+3,896
| +6% | +$51.7K | 0.03% | 498 |
|
|
2014
Q1 | $808K | Buy |
63,161
+1,089
| +2% | +$14K | 0.03% | 499 |
|
|
2013
Q4 | $759K | Buy |
62,072
+7,296
| +13% | +$93.2K | 0.03% | 482 |
|
|
2013
Q3 | $667K | Buy |
54,776
+34,461
| +170% | +$460K | 0.03% | 504 |
|
|
2013
Q2 | $291K | Buy |
+20,315
| New | +$320K | 0.01% | 773 |
|
Other funds holding MPT
WAM
TW
COPPSERS
SOADOR
DWM
Cambridge Investment Research Advisors's MPT Position: Q2 2026 in Review
Cambridge Investment Research Advisors reduced its Medical Properties Trust (MPT) stake by 1.5% in Q2 2026, selling an estimated $44.5K and leaving 601,230 shares worth $2.78M. The position accounts for 0.01% of the portfolio, ranked #1431.
Cambridge Investment Research Advisors first reported a position in MPT in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.23M in Q4 2019. 154 funds tracked by Wall St. Rank hold MPT as of Q2 2026.
- Cambridge Investment Research Advisors held 601,230 shares of Medical Properties Trust worth $2.78M as of Q2 2026.
- Cambridge Investment Research Advisors sold 8,978 Medical Properties Trust shares in Q2 2026, an estimated $44.5K.
- Medical Properties Trust made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1431 holding.
- Cambridge Investment Research Advisors first reported a position in Medical Properties Trust in Q2 2013 and has held it in 53 quarters since.
- Cambridge Investment Research Advisors's Medical Properties Trust position peaked at $4.23M in Q4 2019.
- 154 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.